68 related articles for article (PubMed ID: 2143872)
1. Immunologic consequence of class II+ pancreatic islet allografts on recipient responsiveness.
Markmann JF; Barker CF; Lo D; Brinster R; Heber-Katz E; Naji A
Transplant Proc; 1990 Aug; 22(4):2052-3. PubMed ID: 2143872
[No Abstract] [Full Text] [Related]
2. The role of HLA class II antigens/genes in xenogeneic iso, allo, and xeno transplantation.
Tsuji K; Hagihara M; Sato T; Shimura T; Takebe K; Munkhbat B
Transplant Proc; 1994 Aug; 26(4):2441-3. PubMed ID: 8066801
[No Abstract] [Full Text] [Related]
3. Prolongation of rat islet allografts with the use of ultraviolet irradiation, without immunosuppression.
Hardy MA; Lau H; Reemtsma K
Transplant Proc; 1984 Jun; 16(3):865-9. PubMed ID: 6233774
[No Abstract] [Full Text] [Related]
4. Manipulation of pancreatic islet cells in allotransplantation.
Tze WJ; Tai J
Transplant Proc; 1982 Dec; 14(4):714-23. PubMed ID: 6820204
[No Abstract] [Full Text] [Related]
5. Lack of tolerance to donor-strain skin grafts in mice with established islet allografts.
Gores DF; Sutherland DE; Platt JL; Bach FH
Transplantation; 1987 May; 43(5):749-50. PubMed ID: 2953095
[No Abstract] [Full Text] [Related]
6. Induced expression of class II major histocompatibility complex antigens on thyroid but not pancreatic islet allografts following transfer of sensitized LYT2+ T cells.
Warren HS; Simeonovic CJ; Allan W; Hume DA
Transplant Proc; 1987 Feb; 19(1 Pt 1):213. PubMed ID: 3152690
[No Abstract] [Full Text] [Related]
7. Immunogenicity of class I+, class II- hepatocytes.
Almond PS; Bumgardner GL; Chen S; Platt J; Payne WD; Matas AJ
Transplant Proc; 1991 Feb; 23(1 Pt 1):108-9. PubMed ID: 1899298
[No Abstract] [Full Text] [Related]
8. A peptide-major histocompatibility complex II chimera favors survival of pancreatic beta-islets grafted in type 1 diabetic mice.
Casares S; Lin M; Zhang N; Teijaro JR; Stoica C; McEvoy R; Farber DL; Bona C; Brumeanu TD
Transplantation; 2008 Jun; 85(12):1717-25. PubMed ID: 18580462
[TBL] [Abstract][Full Text] [Related]
9. "Indirect" acute islet allograft destruction in nonobese diabetic mice is independent of donor major histocompatibility complex and requires host B lymphocytes.
Kupfer T; Beilke JN; Pham K; Buhrman J; Gill RG
Transplant Proc; 2008 Mar; 40(2):462-3. PubMed ID: 18374102
[TBL] [Abstract][Full Text] [Related]
10. Significant manipulative procedures to reduce immunogenicity of human islet allografts.
Ulrichs K; Müller-Ruchholtz W
Transplant Proc; 1989 Feb; 21(1 Pt 3):2727. PubMed ID: 2523162
[No Abstract] [Full Text] [Related]
11. Immune responsiveness against allogeneic platelet transfusions is determined by the recipient's major histocompatibility complex class II phenotype.
Sayeh E; Aslam R; Speck ER; Le-Tien H; Lazarus AH; Freedman J; Semple JW
Transfusion; 2004 Nov; 44(11):1572-8. PubMed ID: 15504162
[TBL] [Abstract][Full Text] [Related]
12. The effect of reduction of class II antigens on the survival of pancreatic allografts.
Spillenaar-Bilgen EJ; Bouwman E; de Bruin RW; Marquet RL; Jeekel J
Transplant Proc; 1989 Feb; 21(1 Pt 1):515-6. PubMed ID: 2495619
[No Abstract] [Full Text] [Related]
13. MHC antigens persist on human fetal pancreatic islet cells even after culture and transplantation into nude mice.
Cochrum KC; Jemtrud S; Lim RC; Hunt TK; Parry G
Transplant Proc; 1989 Feb; 21(1 Pt 3):2653-6. PubMed ID: 2495660
[No Abstract] [Full Text] [Related]
14. Vulnerability of allografts to rejection by MHC class II-restricted T-cell receptor transgenic mice.
Lee MK; Huang X; Jarrett BP; Moore DJ; Desai NM; Moh Lian M; Markmann JW; Deng S; Frank A; Singer A; Velidedeoglu E; Caton AJ; Markmann AJ
Transplantation; 2003 Apr; 75(8):1415-22. PubMed ID: 12717241
[TBL] [Abstract][Full Text] [Related]
15. Depletion of donor Ia+ cells before transplantation does not prolong islet allograft survival.
Gores PF; Sutherland DE; Platt JL; Bach FH
J Immunol; 1986 Sep; 137(5):1482-5. PubMed ID: 3091683
[TBL] [Abstract][Full Text] [Related]
16. Survival of MHC-deficient mouse heterotopic cardiac allografts.
Campos L; Naji A; Deli BC; Kern JH; Kim JI; Barker CF; Markmann JF
Transplantation; 1995 Jan; 59(2):187-91. PubMed ID: 7839439
[TBL] [Abstract][Full Text] [Related]
17. Successful transplantation of adult and fetal mouse pancreas islet cells using anti-class II antibodies.
Kirste G; Wilms H
Transplant Proc; 1987 Oct; 19(5):3957. PubMed ID: 3118531
[TBL] [Abstract][Full Text] [Related]
18. Unique mixed lymphocyte-stimulating determinants in Ed alpha gene-introduced C57BL/6 transgenic mice.
Kimoto M; Seki K; Matsunaga M; Mineta T
Immunology; 1989 Jun; 67(2):154-9. PubMed ID: 2473954
[TBL] [Abstract][Full Text] [Related]
19. Antigen presenting function of class II MHC expressing pancreatic beta cells.
Markmann J; Lo D; Naji A; Palmiter RD; Brinster RL; Heber-Katz E
Nature; 1988 Dec; 336(6198):476-9. PubMed ID: 3143077
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the in vitro presentation of minor lymphocyte stimulating determinants by major histocompatibility complex-encoded immune response genes.
Ryan JJ; Miner DW; Mond JJ; Finkelman FD; Woody JN
J Immunol; 1987 Apr; 138(8):2392-401. PubMed ID: 2435797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
